U.S. Asthma Therapies Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely bronchodilators, anti-inflammatories, bronchodilator/corticosteroid combinations, and other emerging therapies. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.

Table of Contents

U.S. Asthma Therapies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Asthma Therapies Markets, IntroductionOverviewScope and SegmentationDisease DefinitionRisk FactorsDisease ClassificationTreatmentDrug Delivery MethodsSocietal Economic BurdenChallenges and StrategiesDriversRestraintsMarket DynamicsDemand AnalysisMarket and Technology TrendsTotal Market Revenue ForecastMarket Share AnalysisFrost & Sullivan Market Engineering AwardsMarket Leadership Award Strategic Alliance Leadership AwardBrand Awareness Development AwardBusiness Development Strategy AwardTechnology Innovation Award U.S. Asthma Therapies Markets, Bronchodilator Therapies MarketOverviewIntroductionMarket Engineering AnalysisRevenue ForecastCompetitive AnalysisCompetitive StructureMarket Share AnalysisShort-Acting Beta2 Agonist MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingLong-Acting Beta2 Agonist MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingAnticholinergics MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingMethylxanthines MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureProduct Analysis-ExistingU.S. Asthma Therapies Markets, Anti-Inflammatory Therapies MarketOverviewIntroductionMarket Engineering AnalysisRevenue ForecastCompetitive AnalysisCompetitive StructureMarket Share AnalysisInhaled Corticosteroid MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingMediator-Release Inhibitor MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingAnti-Leukotriene MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingOther Emerging Anti-Inflammatory Therapies MarketIntroductionRevenue ForecastCompetitive StructureProduct Analysis-EmergingU.S. Asthma Therapies Markets, Bronchodilator/Corticosteroid Combination Therapies MarketOverviewIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingU.S. Asthma Therapies Markets, Other Emerging Asthma Therapies MarketOverviewIntroductionCompetitive StructureProduct Analysis-Emerging




Related Research

Release Date : 20-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.